According to Astellas Pharma's latest financial reports the company's current revenue (TTM) is £8.33 B. In 2023 the company made a revenue of £8.52 B a decrease over the revenue in the year 2022 that were of £9.08 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.